Navigation Links
Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team
Date:10/29/2012

SAN FRANCISCO, Oct. 29, 2012 /PRNewswire/ -- Principia Biopharma, Inc., a privately-held biopharmaceutical company focused on advancing best-in-class medicines in immunology, autoimmune diseases, and oncology announced that it successfully met its milestone obligations and received its second tranche of funding totaling $12.5 million in July 2012. The investment was led by existing investors New Leaf Venture Partners, OrbiMed Advisors, Morgenthaler Ventures, SROne and Mission Bay Capital.  In February 2011, Principia completed a tiered Series A round of financing totaling $36.3 million and received the first tranche of $12 million that same month.  Proceeds from this most recent financing will be used to advance Principia's lead molecule towards the clinic and to develop additional programs enabled by the company's reversible covalent platform.

(Logo: http://photos.prnewswire.com/prnh/20121029/NY01747LOGO)

Martin Babler, CEO of Principia, says, "We are pleased to complete the closing of our second tranche as it provides the necessary funding for Principia to advance our lead compound toward our first clinical trials in 2013. We appreciate the continued support from our current investors as we invest in important treatments for cancer and autoimmune disorders."

EXPANSION OF SENIOR MANAGEMENT TEAM

As part of Principia's growth and its initiatives to bring new medicines to patients, the company has expanded its senior management team with the hiring of Jens Oliver Funk, M.D. as Chief Scientific Officer (C
'/>"/>

SOURCE Principia Biopharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Regeneron Named Worlds #1 Biopharmaceutical Employer in Science Magazine Annual Survey
2. Biopharmaceutical Industry Veterans Join Inspiration Biopharmaceuticals Board of Directors
3. PDL BioPharma Completes Regular Quarterly Dividend Payment
4. Chester County Biopharmaceutical Firm to Expand, Create 151 New Jobs
5. National Press Club to Host "NEWSMAKER" with PhRMA CEO to Discuss Policy, Budget Threats to Biopharmaceutical Research
6. PDL BioPharma to Present at Upcoming Investor Conferences
7. Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohns Disease
8. The Thousand-Year Business Model for a Modern Biopharmaceutical Company
9. BioWorld Launches Enhanced Biopharma News Site with Data, Analysis
10. Biopharmaceutical Service Providers Announce Collaborative Opening of Boston, MA Office
11. New Stroke Drug from ZZ Biotech Produced by Laureate Biopharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Hearing health affects a man,s lifestyle, and if ... and professionally engaged, he should address any hearing loss he ... Better Hearing Institute (BHI) is delivering to men ... Week , which leads up to and includes Father,s Day. ... through June 16. To help men address ...
(Date:5/23/2013)... -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a ... intellectual property developed and owned by Hadassah University ... research center, today announced that its portfolio company, ... the Israeli Ministry of Industry and Commerce, Office ... development and advance clinical trials. Cell Cure,s development ...
(Date:5/23/2013)... Mich. , May 23, 2013  Every day, their ... of air to his lungs. April and Bryan ... dire predictions weren,t true. "Quite a few doctors ... hospital alive," says April Gionfriddo , about ... desperate. Anything that would work, we would take it and ...
Breaking Medicine Technology:Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4
... Sept. 1, 2011 NxStage® Medical, Inc. (Nasdaq: ... products, today announced that its Chief Executive Officer, Jeffrey ... Tech, The Voice of New England Innovation, 2011 All-Stars ... leaders of New England,s innovation economy. ...
... Therapeutics, Inc. (NASDAQ: HALO ), a ... extracellular matrix , today announced that management ... the William Blair Life Sciences Conference in New ... Boston. (Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO ) ...
Cached Medicine Technology:NxStage Medical Founder and CEO Jeffrey Burbank Honored With Mass High Tech All-Star Award 2NxStage Medical Founder and CEO Jeffrey Burbank Honored With Mass High Tech All-Star Award 3NxStage Medical Founder and CEO Jeffrey Burbank Honored With Mass High Tech All-Star Award 4Halozyme Therapeutics to Present at Upcoming Financial Conferences 2
(Date:5/25/2013)... 2013 It's not astonishing that holidays ... The demands are endless, from family, friends and co-workers. ... who want more than their parents can afford, parties ... season, comes graduations, birthdays, anniversaries and it seems like ... gift ideas become tired and income can’t catch up ...
(Date:5/25/2013)... A disorder of the nerves, Diabetic neuropathy is ... neuropathy expert doctor Helen C Lin, on Medscape at ... affects almost 50% of all Diabetic patients, making neuropathy ... blood sugar levels in the body are the original ... tend to have abnormally high blood sugar levels. When ...
(Date:5/25/2013)... May 25, 2013 Radius Engineering ... shelter company in the US and has been ... for over 35 years. M.E. and President, Walton ... of NBC Weapon Fundamentals and Shelter Engineering Standards, ... bible on shelter engineering. McCarthy is considered the ...
(Date:5/25/2013)... Pradaxa lawsuits filed on behalf ... bleeding while using the blood thinner continue to mount in ... of Illinois, Bernstein Liebhard LLP reports. According to a ... had been filed in the litigation as of ... by the Court on May 15th. ( In Re: Pradaxa ...
(Date:5/25/2013)... Many orthodontists have thought about moving their office ... is. Most people would naturally assume that the ... cloud service and support would own and maintain all ... they'd be wrong. Cloud providers lease space in ... that houses servers and related equipment to run cloud ...
Breaking Medicine News(10 mins):Health News:TheBeautyPlace.com Debuts Their Brand New Beauty Kits 2Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2
... Nov. 16 The nation,s premier public health agency, the ... two-year contract with Georgia Power to purchase renewable energy for ... http://www.newscom.com/cgi-bin/prnh/20050216/CLW066LOGO ) , The purchase of more ... the organization,s annual kilowatt-hour consumption, will make the CDC Georgia ...
... treatment could result from packaging one of the newer ... that blocks a primordial survival technique in which the ... While they are powerful killers of some breast cancer ... inhibitors, also increase self-digestion, or autophagy, in surviving, mega-stressed ...
... is the most widely used illicit drug by adolescents, ... having experimented with it. Continued marijuana use may result ... impairment, cardiovascular disease, and certain forms of cancer. As ... adolescents and numerous behavioral and medical scientists have been ...
... PLYMOUTH MEETING, Pa., Nov. 16 In this era of healthcare ... and being forced to make tough decisions affecting patients and their ... attention, knowing which ones to focus on can be a challenge. ... plans around the country, ECRI Institute(R) ( www.ecri.org ), ...
... , MILWAUKEE and MENASHA, Wis., Nov. ... Affinity Health System (Affinity) announced today a new agreement that ... the award-winning health system at in-network rates and benefit levels. ... the broadest networks of doctors, hospitals and specialists in the ...
... between Prilosec, Protonix and blood-thinners such as Plavix , MONDAY, ... reflux drugs Prilosec or Protonix in combination with blood ... people who don,t take the two popular antacids, a new ... is being presented Monday at the annual meeting of the ...
Cached Medicine News:Health News:Georgia Power, Centers for Disease Control and Prevention Forge Green Energy Partnership 2Health News:New combination therapy could deliver powerful punch to breast cancer 2Health News:The straight dope: Studies link parental monitoring with decreased teen marijuana usage 2Health News:ECRI Institute Issues Health Plan Watch List: 2010 Top 7 Technologies; Exclusive Insights in White Paper, Available for Free Download 2Health News:ECRI Institute Issues Health Plan Watch List: 2010 Top 7 Technologies; Exclusive Insights in White Paper, Available for Free Download 3Health News:Anthem Blue Cross and Blue Shield Adds Affinity Health System to Provider Network 2Health News:Anthem Blue Cross and Blue Shield Adds Affinity Health System to Provider Network 3Health News:Certain Reflux Drugs Tied to Higher Post-Angioplasty Death Rate 2Health News:Certain Reflux Drugs Tied to Higher Post-Angioplasty Death Rate 3
Desmarres Infant Retractor...
Size 4 - 2.25 mm...
... the features of phaco systems costing much ... maintenance. Small, light and tough enough to ... cost reusable tubing kit can be auto-claved ... a price objection to purchasing a modern ...
Compact ultrasonic phacoemulsification system....
Medicine Products: